Correlation Between Johnson Johnson and Immunoprecise Antibodies
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Immunoprecise Antibodies, you can compare the effects of market volatilities on Johnson Johnson and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Immunoprecise Antibodies.
Diversification Opportunities for Johnson Johnson and Immunoprecise Antibodies
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Johnson and Immunoprecise is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Immunoprecise Antibodies go up and down completely randomly.
Pair Corralation between Johnson Johnson and Immunoprecise Antibodies
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.12 times more return on investment than Immunoprecise Antibodies. However, Johnson Johnson is 8.15 times less risky than Immunoprecise Antibodies. It trades about -0.21 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.21 per unit of risk. If you would invest 16,031 in Johnson Johnson on August 29, 2024 and sell it today you would lose (579.00) from holding Johnson Johnson or give up 3.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Immunoprecise Antibodies
Performance |
| Timeline |
| Johnson Johnson |
| Immunoprecise Antibodies |
Johnson Johnson and Immunoprecise Antibodies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Immunoprecise Antibodies
The main advantage of trading using opposite Johnson Johnson and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| Immunoprecise Antibodies vs. Eliem Therapeutics | Immunoprecise Antibodies vs. Scpharmaceuticals | Immunoprecise Antibodies vs. Milestone Pharmaceuticals | Immunoprecise Antibodies vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |